WeVote
Log In

Bill

Bill

HB 1407

Compounding Pharmacies

2025 Regular Session Introduced by Jenna Persons-Mulicka

Florida bill regulating compounding pharmacies to increase safety oversight died in subcommittee after failing to gain legislative support.

Died in Health Professions & Programs Subcommittee
#regulationofprofessionsandoccupations
0
WeVote Research Nonpartisan
Bill Summary · HB 1407

Legislative bill overview

HB 1407 addresses regulations for compounding pharmacies in Florida, which are pharmacies that create customized medications by mixing, combining, or altering pharmaceutical ingredients. The bill died in subcommittee in June 2025 after being withdrawn from consideration in May, failing to advance through the legislative process.

Why is this important

Compounding pharmacies serve patients with allergies, specific dosage needs, or discontinued medications, but operate with less oversight than traditional pharmacies. Regulatory clarity directly affects medication safety, patient access to specialized treatments, and the competitive landscape between compounding and commercial pharmacies.

Potential points of contention

  • Regulatory burden vs. innovation: Stricter regulations may protect patients but could limit smaller compounding pharmacies' operations or increase medication costs
  • Patient access concerns: Enhanced requirements might reduce availability of customized medications for patients with specialized needs or allergies
  • Industry competition: Traditional pharmacy chains may support tighter regulations to limit compounding pharmacy competition, while compounders resist restrictions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.